The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
December 2nd 2024
Ustekinumab-kfce is planned for launch in February 2025 according to a previous settlement and license agreement with Janssen.
November 27th 2024
November 26th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Osteoarthritis Summit Set For June 2011
June 30th 2010For the first time, Hospital for Special Surgery will host an international Osteoarthritis Summit in June 2011 that will bring together a comprehensive multidisciplinary group of world renowned scientists, thought-leaders and industry representatives from the US, Canada, and Europe.
Vitamin D results in more-not fewer-falls and fractures in older women
June 28th 2010lder community-dwelling women who receive annual high-dose cholecalciferol (vitamin D) experience more falls and fractures-and more fractures unrelated to falls-than those who do not. This unexpected adverse outcome may be dose-related.
Current treatments are good medicine for children with Lyme arthritis
June 28th 2010Children with Lyme arthritis have an excellent prognosis. Treatment of patients who have antibiotic-refractory Lyme arthritis with NSAIDs, intra-articular corticosteroid injections, or disease-modifying antirheumatic drugs (DMARDs) is safe and effective, with no evidence of chronic arthritis, permanent joint changes, or breakthrough cases of persistent infection.
Challenging the intervertebral disk degeneration paradigm
June 28th 2010Traditionally recognized factors, such as age and biomechanics (abnormal physical loading), may play a role in the manifestation of intervertebral disk degeneration, according to researchers in the department of orthopaedics & traumatology at the University of Hong Kong. However, additional factors also may contribute.
RA Task Force Recommendations and Future Treatment
June 8th 2010(AUDIO) The implications of international task force recommendations for future RA treatment are the focus of this discussion from Stephen A. Paget, MD, Chairman of the Division of Rheumatology at the Hospital for Special Surgery in New York.
The primary care physician's guide to inflammatory arthritis: Diagnosis
June 2nd 2010Inflammatory arthritis includes a variety of diseases; the most common are rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. A large proportion of patients seen in most rheumatology practices have inflammatory arthritis; these patients also are seen in the primary care setting, where they present initially before a diagnosis has been made. The inflammatory arthritides are chronic progressive diseases that can cause irreversible joint damage even early in the disease course.
Aromatase Inhibitor-Associated Arthralgia May be Influenced by Genetics
June 2nd 2010Investigators presented new research that reveals a possible genetic basis for why Aromatase inhibitor-associated arthralgia (AIAA) occurs in breast cancer survivors and shows promise for treating the side effect without interfering with the drug's efficacy.
Inflammatory bone loss in joint replacements: The mechanisms
June 1st 2010More than 1 million total joint arthroplasties (TJAs) are performed in the United States each year, and much higher demand is projected. Most TJAs are successful, but aseptic loosening of implants remains a problem that limits long-term success. Aseptic osteolysis, an inflammatory reaction, occurs in up to 10% of patients at 10 years postsurgery.